Effectiveness and cost-effectiveness of monitoring spondyloarthritis with the integrated eHealth system SpA-Net: a randomized controlled trial

ReumaNederland0 个研究点目标入组 200 人开始时间: 待定最近更新: 2024年6月11日

试验速览

•In order to be eligible for participation in this study, subjects must meet all of the following criteria: • Adult patient (18+ years) • Diagnosis of SpA according to treating physician • At least 2 years of disease duration, to be familiar with signs, symptoms, and medication • Stable disease, defined as being in a patient acceptable symptom state according to patient AND treating physician (36) AND no treatment change expected in the next few months • Access to a computer, tablet and/or smartphone for the entire duration of the study

•A potential subject who meets any of the following criteria will be excluded from participation in this study: • Insufficient mastery of Dutch language • Incompetent to act for oneself • Limited life expectancy • Ongoing (or planned) pregnancy during the study period • Patients participating in other research project(s)

发起方

ReumaNederland